digital health companies weight loss glp-1

digital health companies weight loss glp-1 Miami's eMed just hit a $2 billion valuation—and Tom Brady is now its chief wellness officer. The company raised $200 million in series A funding to advance its AI-powered platform Low-Cost Ways Coaches Launch GLP-1

Name: digital health companies weight loss glp-1 Miami's eMed just hit a $2 billion valuation—and Tom Brady is now its chief wellness officer. The company raised $200 million in series A funding to advance its AI-powered platform Low-Cost Ways Coaches Launch GLP-1
Brand: www.cmvroncone.com
SKU: 73069149
Price: 21.23 USD
Availability: InStock
Rating: 4.8028 (18 reviews)

SKU: 73069149

4.8

USD21.23 USD46.23

Pay in 4 interest-free payments of $5.31 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

Description

Most importantly, improvement in glucose control and weight reduction are obtained without increasing the overall risk of hypoglycemia and the number of severe hypoglycemic events

Studied in preclinical models for its role in metabolic and mitochondrial biology research

Tirzepatide, a dual GIP/GLP-1 receptor agonist, has shown even greater efficacy in some studies, with weight reductions of approximately 20% in the SURMOUNT-1 trial